ISRG vs. EW, SNY, ELV, SYK, MDT, PFE, VRTX, REGN, BSX, and AMGN
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Sanofi (SNY), Elevance Health (ELV), Stryker (SYK), Medtronic (MDT), Pfizer (PFE), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Boston Scientific (BSX), and Amgen (AMGN). These companies are all part of the "medical" sector.
Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking.
In the previous week, Intuitive Surgical had 10 more articles in the media than Edwards Lifesciences. MarketBeat recorded 30 mentions for Intuitive Surgical and 20 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 0.72 beat Edwards Lifesciences' score of 0.67 indicating that Edwards Lifesciences is being referred to more favorably in the media.
Intuitive Surgical has a net margin of 27.16% compared to Intuitive Surgical's net margin of 23.01%. Intuitive Surgical's return on equity of 22.86% beat Edwards Lifesciences' return on equity.
Edwards Lifesciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500.
Edwards Lifesciences presently has a consensus price target of $93.88, suggesting a potential upside of 5.31%. Intuitive Surgical has a consensus price target of $396.17, suggesting a potential downside of 0.67%. Given Intuitive Surgical's higher probable upside, equities research analysts plainly believe Edwards Lifesciences is more favorable than Intuitive Surgical.
Edwards Lifesciences received 295 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 71.82% of users gave Edwards Lifesciences an outperform vote while only 69.05% of users gave Intuitive Surgical an outperform vote.
79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 0.9% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
Intuitive Surgical beats Edwards Lifesciences on 11 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
